• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
Upregulation of the Endothelin System in the IUGR Rat Model Induced by Maternal Hyperinsulinemia
Home ‹ 2011 Abstracts ‹ Upregulation of the Endothelin System in the IUGR Rat Model Induced by Maternal Hyperinsulinemia

Exogenous hyperisulinemia causes intrauterine growth restriction (IUGR) and abrogation of the normal gestational blood pressure (BP) decline in rats, associated with shallower implantation site (mesometrial triangle, MT). We demonstrated altered expression of nitric oxide synthase (NOS) system in the placenta and MT of hyperinsulinemic dams (HD). We investigated the endothelin system, which counteracts the vasodilating effect of NO, in our IUGR rat model.

Rats were rendered hyperinsulinemic, mated and followed to pregnancy day 21. Endothelin-converting enzyme (ECE)-1 expression was examined by western blot in the placenta and MT, kidneys, heart and liver of HD. Immunostaining for ECE-1 and endothelin receptor A (ET-A) was quantified by an automated image analysis system.

HD had higher BP than normal pregnant dams (NPD) (130±17mmHg in HD vs. 115±16mmHg in NPD, p<0.05), lower placenta weight (0.44±0.08g in HD vs. 0.47±0.08 NPD, p< 0.05) and reduced fetal weight (males 4.9±0.4g in HD vs. 5.5±0.4g in NPD, p<0.0001; females 4.7±0.4g in HD vs. 5.2±0.4g in NPD, p<0.0001). ECE-1 protein expression was significantly increased in the placenta and the MT of HD by 46% and 48%, respectively, and in the kidney and heart of HD by 230% and 220%, respectively, but not in the liver. Immunostaining revealed expression of ECE-1 and its receptor ET-A, a mediator of vasoconstriction, in trophoblasts of the placenta, MT and endovascular trophoblasts.

Conclusion: ECE-1 and ET-A, mediators of vasoconstriction, are expressed in trophoblastic cells in the placenta and MT. Their overexpression in HD may affect local endothelin levels, and may be one of the factors leading to IUGR.

Authors:

I Ariel, M Khamaisi, G Skarzinski, M Bursztyn.
Departments of Pathology and Medicine, Hadassah Hebrew-University Medical Center, Mount-Scopus, Jerusalem; Institute of Endocrinology, Diabetes & Metabolism 
& Internal Medicine C, Rambam Medical Center & RB Rappaport Faculty of Medicine, Technion, Haifa.

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top